Clinical Trial Update: Atorvastatin in Moderate Active Crohns Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating atorvastatin for moderate active Crohn's disease has completed, sponsored by Skane University Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Skane University Hospital | Conditions: Crohns Disease | Phase 2 | Status: COMPLETED